The regulation of accumulation and function of PPARγ+ Treg by leptin and adiponectin represents a potentially valuable therapeutic pathway that may, in the future, be targeted in order to regulate obesity-related pathologies. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.